SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
Piotr Mordzonek
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
SK&S advised Heineken International B.V. in connection with its approx. PLN 1.66 billion (approx. EUR 347 million) acquisition of the…
